In any given year, depression affects more than 6 percent of the adult population in the United
States—some 16 million people—but fewer than half receive the treatment they need. What if an
algorithm could scan social media and point to linguistic red flags of the disease before a formal
medical diagnosis had been made?

New research from the University of Pennsylvania and Stony Brook University published in the
Proceedings of the National Academy of Sciences shows this is now more plausible than ever.

Analyzing social media data shared by consenting users across the months leading up to a
depression diagnosis, the researchers found their algorithm could accurately predict future
depression. Indicators of the condition included mentions of hostility and loneliness, words like
“tears” and “feelings,” and use of more first-person pronouns like “I” and “me.”

“What people write in social media and online captures an aspect of life that’s very hard in
medicine and research to access otherwise,” says H. Andrew Schwartz, senior paper author and a
principal investigator of the World Well-Being Project (WWBP). “It’s a dimension that’s
relatively untapped compared to biophysical markers of disease. Considering conditions such as
depression, anxiety, and PTSD, for example, you find more signals in the way people express
themselves digitally.”

For six years, the WWBP, based in Penn’s Positive Psychology Center and Stony Brook’s
Human Language Analysis Lab, has been studying how the words people use reflect inner
feelings and contentedness. In 2014, Johannes Eichstaedt, WWBP founding research scientist
and a postdoctoral fellow at Penn, started to wonder whether it was possible for social media to
predict mental health outcomes, particularly for depression.

“Social media data contain markers akin to the genome,” Eichstaedt explains. “With surprisingly
similar methods to those used in genomics, we can comb social media data to find these markers.
Depression appears to be something quite detectable in this way; it really changes people’s use
of social media in a way that something like skin disease or diabetes doesn’t.”

Eichstaedt and Schwartz teamed with colleagues Robert J. Smith, Raina Merchant, David Asch,
and Lyle Ungar from the Penn Medicine Center for Digital Health for this study. Rather than do
what previous studies had done—recruit participants who self-reported depression—the
researchers identified data from people consenting to share Facebook statuses and electronic
medical-record information, and then analyzed the statuses using machine-learning techniques to
distinguish those with a formal depression diagnosis.

“This is early work from our Social Mediome Registry from the Penn Medicine Center for
Digital Health,” Merchant says, “which joins social media with data from health records. For this
project, all individuals are consented, no data is collected from their network, the data is
anonymized, and the strictest levels of privacy and security are adhered to.”

Nearly 1,200 people consented to provide both digital archives. Of these, just 114 people had a
diagnosis of depression in their medical records. The researchers then matched every person with
a diagnosis of depression with five who did not have such a diagnosis, to act as a control, for a
total sample of 683 people (excluding one for insufficient words within status updates). The idea
was to create as realistic a scenario as possible to train and test the researchers’ algorithm.

“This is a really hard problem,” Eichstaedt says. “If 683 people present to the hospital and 15
percent of them are depressed, would our algorithm be able to predict which ones? If the
algorithm says no one was depressed, it would be 85 percent accurate.”

To build the algorithm, Eichstaedt, Smith, and colleagues looked back at 524,292 Facebook
updates from the years leading to diagnosis for each individual with depression and for the same
time span for the control. They determined the most frequently used words and phrases and then
modeled 200 topics to suss out what they called “depression-associated language markers.”

Finally, they compared in what manner and how frequently depressed versus control participants
used such phrasing.

They learned that these markers comprised emotional, cognitive, and interpersonal processes
such as hostility and loneliness, sadness and rumination, and that they could predict future
depression as early as three months before first documentation of the illness in a medical record.

“There’s a perception that using social media is not good for one’s mental health,” Schwartz
says, “but it may turn out to be an important tool for diagnosing, monitoring, and eventually
treating it. Here, we’ve shown that it can be used with clinical records, a step toward improving
mental health with social media.”

Eichstaedt sees long-term potential in using these data as a form of unobtrusive screening.

“The hope is that one day, these screening systems can be integrated into systems of care,” he says.
“This tool raises yellow flags; eventually the hope is that you could directly funnel people it
identifies into scalable treatment modalities.”

Despite some limitations to the study, including its strictly urban sample, and limitations in the
field itself—not every depression diagnosis in a medical record meets the gold standard that
structured clinical interviews provide, for example—the findings offer a potential new way to
uncover and get help for those suffering from depression.


Funding for the research came from the Robert Wood Johnson Foundation and the Templeton
Religion Trust (Grant TRT0048).

Johannes Eichstaedt is founding research scientist of the World Well-Being Project and a
postdoctoral fellow in the Department of Psychology in the School of Arts and Sciences at the
University of Pennsylvania.

Robert J. Smith is a dermatology resident at the Hospital of the University of Pennsylvania and a
former research fellow at the Penn Medicine Center for Digital Health.

Raina Merchant is the director of the Penn Medicine Center for Digital Health and an associate
professor in the Department of Emergency Medicine at the Perelman School of Medicine at the
University of Pennsylvania.

H. Andrew Schwartz is a principal investigator of the World Well-Being Project, a collaborator
of the Penn Medicine Center for Digital Health, and an assistant professor of computer science
at Stony Brook University.

Other collaborators from Penn include Lyle Ungar, Patrick Crutchley, Daniel Preoţiuc-Pietro,
and David Asch.

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided more than $500 million to benefit our community.